Work

LMO2 Facilitates Synthetic Lethality after PARP Inhibition (PARPi) in Diffuse Large B-Cell Lymphoma (DLBCL)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110825

Authors: Ramiro E Verdun, Salma Parvin, Ariel Ramirez Labrada, Gabriel Emmanuel Santiago, Cortizas M Elena, Sharabi Eden, Aumann Shlomzion, Zhang Yu, Isidro Sanchez-Garcia, Francisco Vega, Jennifer Rose Chapman-Fredricks, Izidore S. Lossos

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Universidad de Salamanca, Instituto de Biología Molecular y Celular del Cáncer de Salamanca

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2915949800

Cites:

Cited by: 1

Related to: 10